Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01164085 · ClinicalTrials.gov registry record · Phase 1
Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01164085 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 10 participants.
The verdict
NCT01164085, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Intraocular delivery of ketorolac will be an effective means to treat inflammation and macular edema and prevent structural complications and vision loss in patients with uveitis who are unable to tolerate corticosteroids due to their side effects.
Interventions
- DRUG Intravitreal Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01164085
The ClinicalTrials.gov registry entry for NCT01164085 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intravitreal Ketorolac is the first listed.
NCT01164085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01164085 about?
NCT01164085 is a clinical study titled "Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study". Intraocular delivery of ketorolac will be an effective means to treat inflammation and macular edema and prevent structural complications and vision loss in patients with uveitis who are unable to tolerate corticosteroids due to their side effects.
What is the current status of trial NCT01164085?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2009-12. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01164085?
The interventions under investigation include: Intravitreal Ketorolac (DRUG).
Who is sponsoring clinical trial NCT01164085?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.